UK markets open in 7 hours 36 minutes

AMAG Pharmaceuticals, Inc. (AMAG)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
13.70+0.02 (+0.15%)
At close: 4:00PM EDT

13.70 0.00 (0.00%)
After hours: 4:03PM EDT

Show:
Income statement
Balance sheet
Cash flow
Annual
Premium required to access quarterly data
Quarterly

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
31/12/2017
31/12/2016
Total revenue
297,696
327,751
474,002
609,946
532,091
Cost of revenue
106,965
107,193
215,892
183,166
116,889
Gross profit
190,731
220,558
258,110
426,780
415,202
Operating expenses
Research development
51,250
64,853
44,846
75,017
66,084
Selling general and administrative
227,109
286,870
277,417
291,900
211,658
Total operating expenses
278,359
351,723
322,263
382,636
290,271
Operating income or loss
-87,628
-131,165
-64,153
44,144
124,931
Interest expense
24,820
24,297
51,971
68,382
73,153
Total other income/expenses net
-147,108
-313,914
-18,889
-348,666
-45,872
Income before tax
-258,689
-466,503
-129,685
-370,094
9,055
Income tax expense
150
-47
39,654
-170,866
11,538
Income from continuing operations
-258,839
-466,456
-169,339
-199,228
-2,483
Net income
-258,839
-466,456
-65,761
-199,228
-2,483
Net income available to common shareholders
-258,839
-466,456
-65,761
-199,228
-2,483
Basic EPS
-
-13.71
-1.91
-5.71
-0.07
Diluted EPS
-
-13.71
-1.91
-5.71
-0.07
Basic average shares
-
34,030
34,394
34,907
34,346
Diluted average shares
-
34,030
34,394
34,907
34,346
EBITDA
-
-414,882
94,509
-146,174
182,094